Zifo Launches AI Antibody Engineering App on Snowflake

Zifo Technologies has launched its AI-powered Antibody Engineering application on the Snowflake Marketplace, announced in a press release. This cloud-native GenAI platform is designed to accelerate the design and optimization of therapeutic antibodies, potentially shortening the timeline for new drug discovery.

The application supports three open-source models—ProtGPT2, ESM, and RoBERTa—allowing users to benchmark and tailor models within a single environment. This flexibility aims to improve the hit rate for high-affinity therapeutic antibodies by integrating state-of-the-art AI into a seamless workflow.

Leveraging Snowflake's platform, the app provides a no-code interface for scientists and bioinformaticians to fine-tune protein language models on proprietary datasets securely. The platform facilitates the entire discovery pipeline, from generating novel antibody sequences to predicting their 3D structures and analyzing key regions.